Physician profile
Michael C Maxwell
NPI 1467401752
$4,038.33
in general payments reported to CMS, 2019-2025
41 companies · $350 in 2025
The $350 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $933 · 2020: $197 · 2021: $528 · 2022: $533 · 2023: $773 · 2024: $724 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,847.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,846.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $478.60 | 2019-2024 | |
| Lilly USA, LLC | $424.34 | 2020-2024 | Jardiance, Mounjaro, Emgality |
| Astrazeneca Pharmaceuticals LP | $361.00 | 2019-2024 | Airsupra, Breztri |
| Astellas Pharma US INC | $327.10 | 2019-2024 | Veozah |
| Novo Nordisk INC | $195.70 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $179.51 | 2020-2025 | Shingrix, Bexsero, Arexvy |
| Amarin Pharma, INC. | $175.16 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $171.29 | 2019-2024 | Gardasil, Capvaxive, Gardasil 9 |
| Biohaven Pharmaceutical Holding Company LTD. | $159.08 | 2022 | |
| Pfizer INC. | $155.39 | 2023-2025 | |
| Allergan, INC. | $137.30 | 2019 | |
| Genentech USA, INC. | $130.98 | 2019-2021 | |
| Abbott Laboratories | $118.20 | 2022-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $86.31 | 2022-2024 | Dexcom G6 Transmitter |
| Biogen, INC. | $81.79 | 2025 | Skyclarys |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $81.04 | 2023-2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $77.18 | 2021-2024 | Spravato |
| Eisai INC. | $73.94 | 2020-2024 | |
| Cranial Technologies, INC | $60.84 | 2023-2024 | Doc Band |
| Sanofi Pasteur INC. | $56.38 | 2019-2023 | |
| Amgen INC. | $49.90 | 2021-2024 | Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.89 | 2021-2024 | Jardiance |
| Medicomp INC | $40.18 | 2025 | Telepatch Cardiac Monitor |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $35.94 | 2022-2025 | Xifaxan |
| Tris Pharma INC | $33.15 | 2023 | Dyanavel Xr |
| Esperion Therapeutics, INC. | $32.32 | 2021 | |
| Sanofi-Aventis U.S. LLC | $29.43 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $22.93 | 2019-2020 | |
| Abiomed | $22.70 | 2024 | Impella |
| Boston Scientific Corporation | $19.81 | 2019 | |
| Vifor Pharma, INC. | $19.76 | 2019 | |
| Idorsia Pharmaceuticals US INC | $19.23 | 2023 | Quviviq |
| Si-Bone, INC. | $17.59 | 2020 | |
| Optos, INC. | $16.61 | 2021 | |
| Xeris Pharmaceuticals, INC. | $16.13 | 2025 | Gvoke Hypopen |
| Inogen, INC. | $15.27 | 2025 | |
| Ironshore Pharmaceuticals INC. | $14.88 | 2019 | |
| Medtronic, INC. | $14.63 | 2025 | Venaseal |
| Seqirus USA INC | $13.89 | 2024 | Fluad, Flucelvax |
| Arbor Pharmaceuticals, INC. | $11.91 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $11.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Maxwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.